Quality of life with macular degeneration: Perceptions of patients, clinicians, and community members

British Journal of Ophthalmology

Volumn 87, Issue 1, 2003, Pages 8-12

  Stein, J D ^a,b,c   Brown, M M ^a,b   Brown, G C ^a,b   Sharma, S ^a,d   Hollands, H ^d  

^a Ctr Evidence Based Hlth Care Econ   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PERSONNEL; METHODOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETINA MACULA DEGENERATION; STATISTICAL ANALYSIS; VISION; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; FEMALE; HEALTH STATUS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0037230255     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.1.8     Document Type: Article

References (28)

1. National Advisory Eye Council. Vision Research, a National Plan, 1994-1998. NIH publication 93-3186. Bethesda, MD: US Dept Health and Human Services, 1993.
2. Williams RA, Brody BL, Thomas RG, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998;116:514-20.
3. Brown MM, Brown GC, Sharma S, et al. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol 1999;10:221-6.
4. Ware JE. SF-36 Health Survey: Manual and Interpretive Guide. Boston: Health Institute, New England Medical Center, 1993.
5. Kaplan RM, Anderson JP. A general health policy model: Update and applications. Health Serv Res 1988;23:203-35.
6. Mangione CM, Phillips RS, Seddon JM, et al. Development of the "Activities of Daily Vision Scale": A measure of visual functional status. Med Care 1992;30:1111-12.
7. Gold MR, Russell LB, Siegel JE, et al, eds. Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
8. Redelmeier DA, Detsky AS. A clinician's guide to utility measurement (Review). Prim Care 1995;22:271-80.
9. Froberg DG, Kane RL. Methodology for measuring health-state preferences-II: Scaling methods. J Clin Epidemiol 1989;42:459-71.
10. Torrance GW. Measurement of health state utilities for economic appraisal (Review). J Health Econ 1986;5:1-30.
11. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-75.
12. Brown GC, Sharma S, Brown MM, et al. Evidence-based medicine and cost-effectiveness. J Health Care Finance 1999;26:14-23.
13. George D, Mallery P. SPSS for Windows Step by Step. 2nd Ed. Boston, MA: Allyn & Bacon, 2000.
14. Norusis MJ. SPSS 9.0 Guide to Data Analysis. Prentice Hall. Upper Saddle River, NJ. 1997.
15. Mangione CM, Gutierrez PR, Lowe G, et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol 1999;128:45-53.
16. Hazel CA, Petre KL, Armstrong RA, et al. Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest Ophthalmol Vis Sci 2000;41:1309-15.
17. Stein JD, Brown GC, Brown MM, et al. The quality of life of patients with hypertension. J Clin Hypertens 2002;4:181-8.
18. Lalonde L, Clarke AE, Joseph L, et al. Comparing the psychometric properties of preference-based and nonpreference-based health-related quality of life in coronary heart disease. Canadian Collaborative Cardiac Assessment Group. Qual Life Res 1999;8:399-409.
19. Samsa GP, Matchar DB, Goldstein L, et al. Utilities for major stroke: Results from a survey of preferences among persons at increased risk for stroke. Am Heart J 1998;136:703-13.
20. Brown MM, Brown GC, Sharma S, et al. Utility values associated with blindness in an adult population. Br J Ophthalmol 2001;85:327-31.
21. Brown GC, 8rown MM, Sharma S. Difference between ophthalmologist and patient perceptions of quality-of-life associated with age-related macular degeneration. Can J Ophthalmol 2000;35:27-32.
22. Rothwell PM, McDowell Z, Wong CK, et al. Doctors and patients don't agree: Cross sectional study of potients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997;314:1580-3.
23. Schrader GD. Subjective ond objective assessments of medical comorbidity in chronic depression. Psychother Psychosom 1997;66:258-60.
24. Lieberman JR, Dorey F, Shekelle P, et al., Differences between patients' and physicians' evaluations of outcome after total hip arthroplasty. J Bone Joint Surg Am 1996;78:835-8.
25. Jachuck SJ, Brierley H, Jachuck S, et al. The effect of hypotensive drugs on the quality of life. J R Coll Gen Proct 1982;32:103-5.
26. Kahnemann D, Tversky A. Choices, values, and frames. American Psychologists 1983;39:341-50.
27. VanNewkirk MR, Nanjan MB, Wang JJ, et al. The prevalence of age-related maculopathy: The visual impairment project. Ophthalmology 2000;107:1593-600.
28. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degenerotion: Results trom the Blue Mountains Eye Study. Aust NZJ Ophthalmol 1997;25(Suppl 1):S 13-15.